| Code | 1000A | ||||||||||
| MA number | 68/0232/12-S | ||||||||||
| Product Form: | tbl 50x100 mg (blis.PVC/PVDC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 68 - ANTIPSYCHOTICA (NEUROLEPTICA) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 60 | ||||||||||
| Container: | blister PVC/PVDC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 30.04.2012 |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| Dokument: |
EPAR Tiaprid Pharmagen 2012.doc
|
| SPC: |
SPC_Tiaprid PMCS 100mg_01.2020.doc
|
| PIL: |
PIL_Tiaprid PMCS 100mg_01.2020.doc
|
| Safety feature | Yes |
| Data update: | 23.04.2018 |
